BioGaia AB (publ)
BIOG-B
株式のランク
#8088
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
株価
$13.02
時価総額
$1.28B
変化（1日）
3.38%
変化（1年）
14.20%
国
SE
取引 BioGaia AB (publ) (BIOG-B)
カテゴリー
Healthcare
BioGaia AB (publ)（BIOG-B）の株価履歴
終値の最高値: $12.34 （2026-10-01）
終値の最安値: $6.50 （2015-09-01）
終値の最安値: $6.50 （2015-09-01）
BioGaia AB (publ) の株価履歴（2015 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 6.03% |
| 2025 | -0.98% |
| 2024 | 9.23% |
| 2023 | 17.14% |
| 2022 | -25.15% |
| 2021 | -12.80% |
| 2020 | 58.73% |
| 2019 | 5.53% |
| 2018 | 53.85% |
| 2016 | -32.67% |
| 2015 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.72 | 21.69% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.11 | 31.46% |
CH
|
|
| $18.43 | -4.03% |
IN
|
